DV
Dividend Vision

ABVC — ABVC Biopharma Inc

ABVC Biopharma Inc (ABVC)

Its deepest 1-year drawdown was 72.5%.

ABVC Biopharma Inc is an equity fund that focuses on the biopharmaceutical sector, providing exposure to companies operating in drug development and life sciences. The fund does not currently offer a regular distribution yield, making it primarily suited for capital appreciation rather than income generation. This holding is better aligned with growth-oriented investors seeking sector-specific exposure to the biopharma industry rather than dividend-focused income strategies.

ABVC key facts

Asset type
Stock
Asset class
Equity
Inception date
11/10/2004
Last close
$0.90
Market cap
$32,500,552
Average volume
116800.0
Payment date
05/08/2019
Beta
0.538
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.39